Public Engagement Provision. (360G-Wellcome-104832_Z_14_A)
1. How do developments in cancer omics interplay with bio-social differences in the incidence, treatment, prognosis and experience of cancer? 2. What do developments in post-genomic screening and monitoring, pre and postdiagnosis and treatment, mean for cancer patienthood? 3. How do cancer patients engage in and experience cancer omics research and the translational practices this enjoins? 4. How does cancer research manifest in public life, in relation to patients and patienthood?
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Amount Awarded | 4973 |
| Applicant Surname | Kerr |
| Approval Committee | ERG10 Medical Humanities |
| Award Date | 2014-11-25T00:00:00+00:00 |
| Financial Year | 2014/15 |
| Grant Programme: Title | Provision for Public Engagement |
| Internal ID | 104832/Z/14/A |
| Lead Applicant | Prof (Elizabeth) Anne Kerr |
| Partnership Value | 4973 |
| Planned Dates: End Date | 2020-12-31T00:00:00+00:00 |
| Planned Dates: Start Date | 2015-01-01T00:00:00+00:00 |
| Recipient Org: Country | United Kingdom |
| Region | Yorkshire and the Humber |